Rudy Li
Stock Analyst at Chardan Capital
(4.74)
# 119
Out of 4,960 analysts
22
Total ratings
79.17%
Success rate
19.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics | Maintains: Buy | $24 | $19.56 | +22.70% | 4 | Aug 13, 2025 | |
| XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $38.84 | +41.61% | 3 | Aug 12, 2025 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $30 | $17.01 | +76.37% | 3 | Aug 12, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $18 | $8.77 | +105.25% | 6 | Aug 5, 2025 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $20 | $10.19 | +96.27% | 4 | Aug 1, 2025 | |
| DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $43.96 | +81.98% | 2 | May 21, 2025 |
Stoke Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $24
Current: $19.56
Upside: +22.70%
Xenon Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $55
Current: $38.84
Upside: +41.61%
Centessa Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $30
Current: $17.01
Upside: +76.37%
Prothena Corporation
Aug 5, 2025
Maintains: Buy
Price Target: $18
Current: $8.77
Upside: +105.25%
Mind Medicine (MindMed)
Aug 1, 2025
Maintains: Buy
Price Target: $20
Current: $10.19
Upside: +96.27%
Bright Minds Biosciences
May 21, 2025
Maintains: Buy
Price Target: $80
Current: $43.96
Upside: +81.98%